GENZYME CORP Foreign Currency Contract, Asset, Fair Value Disclosure
GENZYME CORP had Foreign Currency Contract, Asset, Fair Value Disclosure of $1.44 million as of 2010-12-31, per its 10-K filed 2011-03-01.
Discontinued › Notes › Fair Value Measures and Disclosures › Financial Instruments, Financial Assets, Balance Sheet Groupings
us-gaap:ForeignCurrencyContractAssetFairValueDisclosure · last filed 2011-03-01
- 2010-12-31: Foreign Currency Contract, Asset, Fair Value Disclosure $1.44M.
- 2010-09-30: Foreign Currency Contract, Asset, Fair Value Disclosure $230.00K.
- 2009-12-31: Foreign Currency Contract, Asset, Fair Value Disclosure $4.28M.
| Period end | Foreign Currency Contract, Asset, Fair Value Disclosure |
|---|---|
| 2010-12-31 | $1.44M 10-K · filed 2011-03-01 |
| 2010-09-30 | $230.00K 10-Q · filed 2010-11-09 |
| 2009-12-31 | $4.28M 10-K · filed 2011-03-01 |